![](https://news.unchealthcare.org/wp-content/uploads/sites/1159/2020/10/eli-lillys-coronavirus-antibody-drug-cut-hospitalization-rates-by-three-fold-for-mild-or-moderately-ill-patients-early-study-data-reveals-600x439.jpg)
September 17, 2020
Eli Lilly’s coronavirus antibody drug cut hospitalization rates by THREE-FOLD for mild or moderately ill patients, early study data reveals
The antibody, LY-CoV555, recognizes the coronavirus and attaches to it, preventing it from spreading throughout the body